Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 57 of 57 entries
View as:

Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT01344083 Org: User:
Start: 04/30/11 End: 02/29/12 Due: 02/28/13

Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00357292 Org: User:
Start: 03/31/02 End: 04/30/02 Due: 04/30/03

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

Phase: N/A Priority: Normal
NCT ID: NCT06627179 Org: User:
Start: 12/11/24 End: 12/31/27 Due: 12/31/28

Safety, Efficacy Assessment of Geltim LP® 1 mg/g in Ocular Hypertensive or Glaucomatous Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01155219 Org: User:
Start: 07/31/08 End: 12/31/09 Due: 12/31/10

Performance and Safety Assessment of T4020 in Managing Corneal Epithelial Defect Following Epi-off Accelerated Crosslinking

Phase: N/A Priority: Normal
NCT ID: NCT02979054 Org: User:
Start: 12/31/16 End: 03/31/18 Due: 03/31/19

Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00357539 Org: User:
Start: 02/28/02 End: 03/31/02 Due: 03/31/03

Efficacy, Safety of T2769 in Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT03830359 Org: User:
Start: 09/01/18 End: 02/18/19 Due: 02/18/20